Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
C 27.72 -0.79% -0.22
PFE closed down 0.79 percent on Monday, March 18, 2024, on 81 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
22 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Up

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
NR7 Range Contraction -0.79%
Overbought Stochastic Strength -0.79%
Gapped Down Weakness -0.79%
Stochastic Sell Signal Bearish -1.46%
Overbought Stochastic Strength -1.46%
Shooting Star Candlestick Bearish -1.77%

   Recent Intraday Alerts

Alert Time
Possible NR7 about 9 hours ago
Fell Below Previous Day's Low about 13 hours ago
Down 1% about 13 hours ago
Possible NR7 3 days ago
60 Minute Opening Range Breakdown 4 days ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Pfizer, Inc. Description

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Major
Keywords: S&P 500 Biopharmaceutical Disease Pain Medication Clinic Neuroscience Pharmaceutical Products Inflammation Alzheimer's Disease Hypertension Dietary Supplement Ophthalmology Animal Health Pain Management Dysfunction Major Depressive Disorder Pulmonary Arterial Hypertension Depressive Disorder Primary Care Smoking Hemophilia Smoking Cessation Anti Infectives Endocrine Disorders Erectile Dysfunction Livestock Producers Prescription Product Prescription Products Genitourinary

Is PFE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 40.154
52 Week Low 25.3781
Average Volume 44,810,386
200-Day Moving Average 31.32
50-Day Moving Average 27.55
20-Day Moving Average 27.32
10-Day Moving Average 27.57
Average True Range 0.62
RSI (14) 52.83
ADX 13.56
+DI 25.82
-DI 22.26
Chandelier Exit (Long, 3 ATRs) 26.84
Chandelier Exit (Short, 3 ATRs) 27.46
Upper Bollinger Bands 28.68
Lower Bollinger Band 25.95
Percent B (%b) 0.65
BandWidth 9.99
MACD Line 0.13
MACD Signal Line -0.01
MACD Histogram 0.1402
Fundamentals Value
Market Cap 156.52 Billion
Num Shares 5.65 Billion
EPS 0.37
Price-to-Earnings (P/E) Ratio 74.92
Price-to-Sales 2.70
Price-to-Book 1.61
PEG Ratio 1.17
Dividend 1.64
Dividend Yield 5.92%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.34
Resistance 3 (R3) 28.38 28.20 28.24
Resistance 2 (R2) 28.20 28.04 28.18 28.20
Resistance 1 (R1) 27.96 27.94 27.87 27.93 28.17
Pivot Point 27.79 27.79 27.74 27.77 27.79
Support 1 (S1) 27.55 27.63 27.46 27.51 27.27
Support 2 (S2) 27.37 27.53 27.35 27.24
Support 3 (S3) 27.13 27.37 27.20
Support 4 (S4) 27.10